Clinical Trials on Relapsed/Refractory Systemic Light Chain Amyloidosis
Total 1027 results
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Regeneron PharmaceuticalsNot yet recruitingRelapsed/Refractory Systemic Light Chain Amyloidosis
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
-
Peking Union Medical College HospitalRecruitingLight Chain (AL) Amyloidosis | Venetoclax | CCND1 TranslocationChina
-
Tufts Medical CenterSanofiWithdrawnAmyloidosis | Light Chain (AL) Amyloidosis
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Nanjing University School of MedicineRecruiting
-
Guangdong Provincial People's HospitalRecruitingImmunoglobulin Light-Chain AmyloidosisChina
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAmyloidosis | Immunoglobulin Light Chain Deposition
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
Sorrento Therapeutics, Inc.WithdrawnLight Chain (AL) Amyloidosis
-
Sorrento Therapeutics, Inc.RecruitingLight Chain (AL) AmyloidosisUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
IRCCS Policlinico S. MatteoTerminatedPrimary Amyloidosis of Light Chain TypeItaly
-
IRCCS Policlinico S. MatteoCompletedPrimary Amyloidosis of Light Chain TypeItaly
-
Jian LiPeking University First Hospital; Tongji Hospital; Nanfang Hospital of Southern... and other collaboratorsCompletedAmyloidosis; SystemicChina
-
European Myeloma NetworkJanssen PharmaceuticaActive, not recruitingLight Chain (AL) Amyloidosis, Stage 3BNetherlands, Greece, France, Italy
-
Nanjing University School of MedicineRecruitingLight Chain AmyloidosisChina
-
Nexcella Inc.Not yet recruitingLight Chain (AL) AmyloidosisUnited States
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingAL Amyloidosis | Amyloid | Refractory AL AmyloidosisUnited States
-
Florian MichelGerman Federal Ministry of Education and ResearchCompletedLight Chain (AL) Amyloidosis | Cardiac InvolvementGermany
-
Prothena Biosciences Ltd.RecruitingLight Chain (AL) AmyloidosisUnited States, Korea, Republic of, Australia, Denmark, France, Italy, Spain, Israel, Taiwan, Austria, Canada, Czechia, Germany, Greece, Hungary, Japan, Netherlands, Poland, Portugal, Turkey, United Kingdom, Belgium, Ireland
-
AbbVieRecruitingImmunoglobulin Light Chain (AL) AmyloidosisJapan
-
M.D. Anderson Cancer CenterTakeda; Janssen PharmaceuticalsActive, not recruitingRecurrent Primary Amyloidosis | Refractory Primary Amyloidosis | Newly Diagnosed Primary AmyloidosisUnited States
-
TakedaCompletedMultiple Myeloma | Immunoglobulin Light-chain AmyloidosisSpain
-
The Cleveland ClinicCompletedAmyloidosis | Spinal Stenosis | Amyloid | Transthyretin Amyloidosis | Primary Amyloidosis of Light Chain TypeUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
The Cleveland ClinicCompletedAmyloidosis | Transthyretin Amyloidosis | Trigger Finger | Primary Amyloidosis of Light Chain TypeUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Jin Lu, MDRecruiting
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
National Cancer Institute (NCI)TerminatedPrimary Systemic AmyloidosisUnited States
-
University Hospital, LimogesMinistry of Health, FranceCompletedPrimary Systemic Amyloidosis (AL)France
-
Boston Medical CenterSpectrum Pharmaceuticals, IncTerminatedAmyloidosis; SystemicUnited States
-
The Cleveland ClinicCompletedPrimary Systemic Amyloidosis
-
Medical College of WisconsinNational Heart, Lung, and Blood Institute (NHLBI)CompletedPrimary Systemic AmyloidosisUnited States
-
University of TennesseeFDA Office of Orphan Products DevelopmentCompleted
-
Jin Lu, MDRecruitingAL Amyloidosis | Amyloidosis; SystemicChina
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
Life Molecular Imaging GmbHpharmtrace klinische Entwicklung GmbHRecruitingAL Amyloidosis | Cardiac Amyloidosis | ATTR AmyloidosisUnited States, Spain, Germany, United Kingdom
-
IRCCS Policlinico S. MatteoWithdrawnPrimary Amyloidosis of Light Chain TypeItaly
-
Mayo ClinicRecruitingAL AmyloidosisUnited States
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; SanofiRecruiting
-
European Myeloma NetworkGlaxoSmithKlineRecruitingAL AmyloidosisGermany, Netherlands, France, Greece, Italy, United Kingdom
-
Tufts Medical CenterTerminatedAL AmyloidosisUnited States